Strengthening Families & Communities LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Strengthening Families & Communities LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13	Closed	-$2.21K	–	633
2025 Q4	$2.21K	Hold	13	–	–	﹤0.01%	316
2025 Q3	$1.71K	Hold	13	–	–	﹤0.01%	505
2025 Q2	$1.38K	Hold	13	–	–	﹤0.01%	303
2025 Q1	$1.61K	Hold	13	–	–	﹤0.01%	308
2024 Q4	$2K	Hold	13	–	–	﹤0.01%	277
2024 Q3	$1.45K	Hold	13	–	–	﹤0.01%	462
2024 Q2	$1K	Buy	+13	New	+$1.43K	﹤0.01%	544

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Strengthening Families & Communities LLC's JAZZ Position: Q1 2026 in Review

Strengthening Families & Communities LLC sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 13 shares — an estimated $2.21K sold.

Strengthening Families & Communities LLC first reported a position in JAZZ in Q2 2024 and held it in 7 quarters. The position peaked at $2.21K in Q4 2025. 573 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Strengthening Families & Communities LLC reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Strengthening Families & Communities LLC sold 13 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.21K.
Strengthening Families & Communities LLC first reported a position in Jazz Pharmaceuticals in Q2 2024 and held it in 7 quarters.
Strengthening Families & Communities LLC's Jazz Pharmaceuticals position peaked at $2.21K in Q4 2025.
573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q1 2026, filed 11 May 2026.